ArticleArchives of Razi Institute2025
Isolation and Antibacterial Properties of Actinomycetesfrom Licorice (
Article in Archives of Razi Institute, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Actinomycetes associated with the medicinal plant licorice ( Materials & Methods: In this study, a total of 75 actinomycete isolates were obtained from licorice plant samples collected in Ilam Province, Iran. These samples were carefully selected due to licorice's traditional use in herbal medicine, suggesting a rich microbial diversity. Results: Molecular identification through Conclusion: The strong correlation between the presence of NRPS genes and antibacterial activity underscores the potential of actinomycetes associated with licorice as a promising source of novel antimicrobial compounds. These findings emphasize the importance of bioprospecting medicinal plant-derived microbiomes as a strategic approach to address the escalating global challenge of antibiotic resistance, paving the way for future research and development in antimicrobial therapies. Future research should focus on elucidating the genetic and metabolic networks that underpin these interactions to fully exploit their pharmaceutical potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.